Diamond Biotechnology Co Ltd Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Diamond Biotechnology Co Ltd

Watchlist Manager

Watchlist

Price: 22.05 TWD -1.56%

Market Cap: NT$875.6m

D	Diamond Biotechnology Co Ltd TPEX:6815	TW
S	Steel PCL SET:THE	TH
	Tantalex Lithium Resources Corporation F:DW8	CA
N	NAT Absolute Technologies PCL SET:NAT	TH
P	Prime Media Holdings Inc XPHS:PRIM	PH
	Tevano Systems Holdings Inc OTC:TEVNF	CA
	Aneka Tambang Tbk PT ASX:ATM	ID
C	Cars Motorcycles and Marine Engine Trade and Import Company SA ATHEX:MOTO	GR
P	Primex Corp XPHS:PRMX	PH
	Demant A/S CSE:DEMANT	DK
I	IDB Technologies Bhd KLSE:IDBTECH	MY
F	Footshop as PSE:FTSHP	CZ
	Kaluzhskaya Sbytovaya Kompaniya PAO MOEX:KLSB	RU
	PT Aracord Nusantara Group Tbk IDX:RONY	ID

Profitability Summary

Diamond Biotechnology Co Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

39%

Sustainable 3Y Average Gross Margin

41%

Declining Gross Margin

43% > 39%

Negative Operating Margin

-12%

Low 3Y Average Operating Margin

Declining Operating Margin

12% > -12%

Negative Net Margin

-10%

Low 3Y Average Net Margin

Declining Net Margin

9% > -10%

Exceptional Free Cash Flow Margin

18%

Negative 3Y Average Free Cash Flow Margin

-1%

Free Cash Flow Margin is Increasing

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.